
The lowdown on Norovirus
Norovirus (or the vomiting bug) is a highly contagious disease characterised by diarrhoea, vomiting, and stomach pain. Symptoms typically develop 12 to 48 hours after being exposed to the virus and usually
Norovirus (or the vomiting bug) is a highly contagious disease characterised by diarrhoea, vomiting, and stomach pain. Symptoms typically develop 12 to 48 hours after being exposed to the virus and usually
hVIVO plc (Euronext / LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced
What is respiratory syncytial virus (RSV) in children? RSV is a respiratory virus that causes illness and trouble breathing. It is more common in winter and early spring months and can
In 1918, about 50 million people, or one-fifth of the world’s population, became infected with the virus known as the “Spanish” flu, according to the Centers for Disease Control and Prevention
Asthma sufferers will often avoid exercise, fearing that it will worsen their condition or induce an asthma attack. Whilst it can be the case that exercise triggers symptoms, this should
hVIVO plc (LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has
Influenza isn’t just limited to certain areas of the world. The flu virus leads to nearly 40 million flu-related illnesses each year even though it is one of the most preventable
The European Medicines Agency (EMA) published an updated Guideline on clinical evaluation of vaccines (EMEA/ CHMP/VWP/164653/05 Rev. 1). This guideline was updated following EMA` s experience in the past decade
hVIVO has signed a new testing contract with an Asia-Pacific based drug maker, which it says is an indication of its growing regional client base. The UK contract research organisation
There are several distinctive features that must be considered in the ATMP development: ATMPs are mainly for the unmet medical needs = severe, rare, or chronic diseases with no adequate